Menu
Main menu
About COG
About COG
Our Impact
Our Research in Childhood Cancers
Early Phase Clinical Trials
Project:EveryChild
Patients & Families
Patients & Families
What is a Clinical Trial
Patient & Family Resources
Return of Results
Member Institutions
Survivorship
Collaborate
Collaborate With Us
Researchers
Industry Partners
Fund Futures
Our Supporters
Ways to Give
Become a Supporter
Donate
News
News
Publications
Donate
Search
Contact Us
Member Login
PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children’s Oncology Group Pediatric Early-Phase Clinical Trial Network Study
October 14, 2025
